MiNK Therapeutics Inc (INKT) Stock Price

11.04 +0.00 (+0.00%)
Open: 11.00 Vol: 4.74K Day's range: 11.00 - 11.205 Feb 13, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
INKT Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 11.12▼ 11.12▼ 11.12▼ 11.07▼ 11.65▼
MA10 11.15▼ 11.18▼ 11.22▼ 11.16▼ 11.77▼
MA20 11.63▼ 11.75▼ 11.80▼ 11.74▼ 12.45▼
MA50 11.97▼ 11.87▼ 11.82▼ 11.87▼ 12.40▼
MA100 11.94▼ 11.96▼ 11.78▼ 12.72▼ 10.48▲
MA200 11.83▼ 12.57▼ 12.93▼ 12.56▼ 13.93▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.057▼ -0.082▼ -0.098▼ -0.086▼ -0.169▼
RSI 32.263▼ 35.019▼ 36.688▼ 38.814▼ 46.445▼
STOCH 14.741▼ 11.703▼ 7.525▼ 17.040▼ 38.988    
WILL %R -96.644▼ -96.644▼ -96.644▼ -89.638▼ -85.594▼
CCI -70.893     -69.412     -73.488     -63.661     -91.874    
Latest Filters Detected On INKT
CDL $INKT Doji Candlestick Pattern Detected Set Alert
MiNK Therapeutics Inc News
MiNK Therapeutics Presents New Data of allo-iNKT Cell Therapy as a Potential Disease-Modifying Approach in Idiopathic Pulmonary Fibrosis at Keystone Symposia
Tuesday, February 03, 2026 06:42 PM
Human lung tissue analyses identify iNKT cell depletion as a mechanistic feature of advanced IPFFindings extend MiNK’s iNKT platform into chronic ...
MiNK Therapeutics and University of Wisconsin–Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease
Thursday, January 08, 2026 09:00 AM
Non-dilutive public-private funded trial with NIAID STTR & Mary Gooze Clinical Trial and Translation Award Expands iNKT platform into transplantation with an off-the-shelf, HLA-independent, ...
MiNK Therapeutics Announces New Data Showing MiNK-215 Drives Potent Anti-Tumor Activity in Treatment-resistant Solid Tumors
Thursday, November 20, 2025 08:43 AM
MiNK-215, an IL-15 armoured FAP-targeting CAR-iNKT, targets and clears tumor-protective FAP+ fibroblasts to allow immune cells to infiltrate and kills cancer cells MiNK-215 is engineered to eliminate ...
INKT historical stock data
date open high low close volume
13/02/26 11.00 11.205 11.00 11.04 4,741
12/02/26 11.216 11.271 10.99 11.04 6,000
11/02/26 11.3812 11.3812 10.98 11.05 2,760
10/02/26 11.45 11.46 11.01 11.19 4,100
09/02/26 10.97 11.48 10.97 11.01 5,500
06/02/26 11.1865 11.35 10.825 10.97 12,679
05/02/26 11.358 11.358 11.00 11.02 11,737
04/02/26 11.17 11.465 11.17 11.465 6,881
03/02/26 11.62 11.6398 10.99 11.22 12,162
02/02/26 11.62 11.715 11.55 11.62 5,492
Quote Details
52wk Low:6.34
52wk High:76.00
Vol:4.74K
Avg Vol(3m):223.3K
1Y Chng:+18.52%
1M Chng:-0.72%
Add to Watch List
More Information
Index US Composite
Market Cap. 51.82M